Dubensky, Jr.; Thomas W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dubensky, Jr.; Thomas W..The latest application filed is for "compositions and methods for activating "stimulator of interferon gene"-dependent signalling".

Company Profile

11.54.47

Dubensky, Jr.; Thomas W. - Berkeley CA
Dubensky, JR.; Thomas W. - Seattle WA
Dubensky, Jr.; Thomas W. - San Diego CA
Dubensky, Jr.; Thomas W. - Piedmont CA
Dubensky, Jr.; Thomas W. - Peidmont CA
Dubensky, Jr.; Thomas W - Piedmont CA US
Dubensky, Jr.; Thomas W. - Rancho Santa Fe CA
Dubensky, JR.; Thomas W. - Del Mar CA
Dubensky, Jr.; Thomas W. - Rancho Sante Fe CA
Dubensky, Jr.; Thomas W. - Del Mod CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for activating "stimulator of interferon gene"13 dependent signalling Grant 11,040,053 - Katibah , et al. June 22, 2	2021-06-22
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling Grant 10,906,930 - Katibah , et al. February 2, 2	2021-02-02
Compositions And Methods For Activating "stimulator Of Interferon Gene"-dependent Signalling App 20200282049 - Dubensky, JR.; Thomas W. ; et al.	2020-09-10
Compositions And Methods For Activating "stimulator Of Interferon Gene" - Dependent Signalling App 20200179431 - Katibah; George Edwin ; et al.	2020-06-11
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling Grant 10,653,774 - Dubensky, Jr. , et al.	2020-05-19
Vaccines For Hsv-2 App 20200023057 - Dubensky, JR.; Thomas W. ; et al.	2020-01-23
Compositions and methods for activating "stimulator of interferon gene"--dependent signalling Grant 10,449,211 - Katibah , et al. Oc	2019-10-22
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use Grant 10,414,789 - Dubensky, Jr. , et al. Sept	2019-09-17
Vaccines for HSV-2 Grant 10,391,164 - Dubensky, Jr. , et al. A	2019-08-27
Compositions And Methods For Activating "stimulator Of Interferon Gene"-dependent Signalling App 20190062365 - KATIBAH; George Edwin ; et al.	2019-02-28
Compositions and methods for inhibiting "stimulator of interferon gene"-dependent signalling Grant 10,189,873 - Dubensky, Jr. , et al. Ja	2019-01-29
Methods And Compositions Using Listeria For Enhancing Immunogenicity By Prime Boost App 20190015488 - Dubensky, Jr.; Thomas W. ; et al.	2019-01-17
Methods For Identifying Inhibitors Of "stimulator Of Interferon Gene"- Dependent Interferon Production App 20180369268 - KATIBAH; George Edwin ; et al.	2018-12-27
Engineered Listeria And Methods Of Use Thereof App 20180280489 - Dubensky, JR.; Thomas W. ; et al.	2018-10-04
Compositions And Methods For Activating "stimulator Of Interferon Gene" - Dependent Signalling App 20180064745 - Katibah; George Edwin ; et al.	2018-03-08
Vaccines for HSV-2 Grant 9,895,435 - Dubensky, Jr. , et al. February 20, 2	2018-02-20
Use Of Sting Agonist As Cancer Treatment App 20180028553 - Gajewski; Thomas F. ; et al.	2018-02-01
Methods and compositions using Listeria for enhancing immunogenicity by prime boost Grant 9,878,024 - Dubensky, Jr. , et al. January 30, 2	2018-01-30
Engineered Listeria And Methods Of Use Thereof App 20180000917 - Dubensky, Jr.; Thomas W. ; et al.	2018-01-04
Compositions And Methods For Activating "stimulator Of Interferon Gene"-dependent Signalling App 20170333552 - Dubensky, JR.; Thomas W. ; et al.	2017-11-23
Compositions Comprising Cyclic Purine Dinucleotides Having Defined Stereochemistries And Methods For Their Preparation And Use App 20170283454 - Dubensky, JR.; Thomas W. ; et al.	2017-10-05
Vaccines for HSV-2 App 20170274066 - Dubensky, JR.; Thomas W. ; et al.	2017-09-28
Compositions and methods for cancer immunotherapy Grant 9,770,467 - Dubensky, Jr. , et al. September 26, 2	2017-09-26
Engineered Listeria and methods of use thereof Grant 9,764,013 - Dubensky, Jr. , et al. September 19, 2	2017-09-19
Signal Peptide Fusion Partners Facilitating Listerial Expression Of Antigenic Sequences And Methods Of Preparation And Use Thereof App 20170253637 - Lauer; Peter M. ; et al.	2017-09-07
Compositions and methods for activating stimulator of interferon gene-dependent signalling Grant 9,724,408 - Dubensky, Jr. , et al. August 8, 2	2017-08-08
Compositions And Methods For Inhibiting "stimulator Of Interferon Gene" -dependent Signalling App 20170218008 - Dubensky, JR.; Thomas W. ; et al.	2017-08-03
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use Grant 9,695,212 - Dubensky, Jr. , et al. July 4, 2	2017-07-04
Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof Grant 9,663,557 - Lauer , et al. May 30, 2	2017-05-30
Vaccines for HSV-2 Grant 9,555,099 - Dubensky, Jr. , et al. January 31, 2	2017-01-31
Compositions and methods for inhibiting "stimulator of interferon gene"--dependent signalling Grant 9,549,944 - Dubensky, Jr. , et al. January 24, 2	2017-01-24
Use Of Sting Agonist As Cancer Treatment App 20160287623 - Gajewski; Thomas F. ; et al.	2016-10-06
Methods And Compositions Using Listeria For Enhancing Immunogenicity By Prime Boost App 20160175415 - Dubensky, JR.; Thomas W. ; et al.	2016-06-23
Methods and compositions using listeria for enhancing immunogenicity by prime boost Grant 9,198,960 - Dubensky, Jr. , et al. December 1, 2	2015-12-01
Immunogenic Composition and Methods of Using the Compositions for Inducing Humoral and Cellular Immune Responses App 20150335733 - Dubensky, JR.; Thomas W. ; et al.	2015-11-26
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses Grant 9,044,420 - Dubensky, Jr. , et al. June 2, 2	2015-06-02
Methods And Compositions Using Listeria For Enhancing Immunogenicity By Prime Boost App 20150125485 - Dubensky, JR.; Thomas W. ; et al.	2015-05-07
Compositions And Methods For Activating Stimulator Of Interferon Gene-dependent Signalling App 20150056224 - Dubensky, JR.; Thomas W. ; et al.	2015-02-26
Compositions And Methods For Cancer Immunotherapy App 20150010613 - Dubensky, JR.; Thomas W. ; et al.	2015-01-08
Methods and compositions using Listeria for enhancing immunogenicity by prime boost Grant 8,926,993 - Dubensky, Jr. , et al. January 6, 2	2015-01-06
Compositions And Methods For Inhibiting "stimulator Of Interferon Gene" -dependent Signalling App 20140341976 - Dubensky, JR.; Thomas W. ; et al.	2014-11-20
Engineered Listeria And Methods Of Use Thereof App 20140315314 - Dubensky, JR.; Thomas W. ; et al.	2014-10-23
Compositions Comprising Cyclic Purine Dinucleotides Having Defined Stereochemistries And Methods For Their Preparation And Use App 20140205653 - Dubensky, JR.; Thomas W. ; et al.	2014-07-24
Signal Peptide Fusion Partners Facilitating Listerial Expression Of Antigenic Sequences And Methods Of Preparation And Use Thereof App 20140186387 - Lauer; Peter M. ; et al.	2014-07-03
Vaccines For Hsv-2 App 20140127247 - Dubensky, JR.; Thomas W. ; et al.	2014-05-08
Vaccines For Hsv-2 App 20140086947 - Dubensky, JR.; Thomas W. ; et al.	2014-03-27
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems Grant 8,647,864 - Polo , et al. February 11, 2	2014-02-11
Engineered Listeria and methods of use thereof Grant 8,580,939 - Dubensky, Jr. , et al. November 12, 2	2013-11-12
Immunogenic Compositions And Methods Of Using The Compositions For Inducing Humoral And Cellular Immune Responses App 20120328655 - Dubensky, JR.; Thomas W. ; et al.	2012-12-27
Synthetic Long Peptide (slp)-based Vaccines App 20120288515 - Robbins; Scott H. ; et al.	2012-11-15
Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines App 20120263754 - Dubensky, JR.; Thomas W. ; et al.	2012-10-18
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof Grant 8,287,883 - Dubensky, Jr. , et al. October 16, 2	2012-10-16
Method for the Purification of Alphavirus Replicon Particles App 20120231526 - Polo; John M. ; et al.	2012-09-13
Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein Grant 8,187,872 - Allen , et al. May 29, 2	2012-05-29
Engineered listeria and methods of use thereof App 20120121643 - Dubensky, JR.; Thomas W. ; et al.	2012-05-17
Nucleic Acid Mucosal Immunization App 20120114693 - VAJDY; MICHAEL ; et al.	2012-05-10
Compositions And Methods For The Treatment Of Hepatitis C App 20120100170 - Lauer; Peter M. ; et al.	2012-04-26
Lentiviral Vectors Pseudotyped with a Sindbis Virus Envelope Glycoprotein App 20120039932 - Allen; James M. ; et al.	2012-02-16
Compositions Comprising Prfa* Mutant Listeria And Mehtods Of Use Thereof App 20110287055 - Lauer; Peter M. ; et al.	2011-11-24
Engineered Listeria And Methods Of Use Thereof App 20110245480 - Dubensky, JR.; Thomas W. ; et al.	2011-10-06
Listeria Attenuated For Entry Into Non-phagocytic Cells, Vaccines Comprising The Listeria, And Methods Of Use Thereof App 20110201092 - Dubensky, JR.; Thomas W. ; et al.	2011-08-18
Eukaryotic layered vector initiation systems Grant 7,977,091 - Dubensky, Jr. , et al. July 12, 2	2011-07-12
Engineered Listeria and methods of use thereof Grant 7,935,804 - Dubensky, Jr. , et al. May 3, 2	2011-05-03
Modified free-living microbes, vaccine compositions and methods of use thereof Grant 7,927,606 - Dubensky, Jr. , et al. April 19, 2	2011-04-19
Lentiviral Vectors Pseudotyped With A Sindbis Virus Envelope Glycoprotein App 20110064763 - Allen; James M. ; et al.	2011-03-17
Recombinant Alphavirus-based Vectors With Reduced Inhibition Of Cellular Macro-molecular Synthesis App 20100330121 - Dubensky, JR.; Thomas W. ; et al.	2010-12-30
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof Grant 7,842,289 - Dubensky, Jr. , et al. November 30, 2	2010-11-30
Modified free-living microbes, vaccine compositions and methods of use thereof Grant 7,833,775 - Dubensky, Jr. , et al. November 16, 2	2010-11-16
Compositions and Methods for Generating an Immune Response Utilizing Alphavirus-Based Vector Systems App 20100266631 - Polo; John ; et al.	2010-10-21
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 7,811,812 - Dubensky, Jr. , et al. October 12, 2	2010-10-12
Methods And Compositions Using Listeria For Enhancing Immunogenicity By Prime Boost App 20100233212 - Dubensky, JR.; Thomas W. ; et al.	2010-09-16
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems Grant 7,771,979 - Polo , et al. August 10, 2	2010-08-10
Eukaryotic Layered Vector Initiation Systems App 20100173412 - Dubensky, JR.; Thomas W. ; et al.	2010-07-08
Enhancement of the immune response for vaccine and gene therapy applications Grant 7,744,900 - Dubensky, Jr. , et al. June 29, 2	2010-06-29
Holin-enhanced Vaccines And Reagents, And Methods Of Use Thereof App 20100129406 - Lauer; Peter M. ; et al.	2010-05-27
Modified free-living microbes, vaccine compositions and methods of use thereof Grant 7,695,725 - Dubensky, Jr. , et al. April 13, 2	2010-04-13
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof Grant 7,691,393 - Dubensky, Jr. , et al. April 6, 2	2010-04-06
Modified Free-living Microbes, Vaccine Compositions And Methods Of Use Thereof App 20100068230 - Dubensky, JR.; Thomas W. ; et al.	2010-03-18
Method For The Purification Of Alphavirus Replicon Particles App 20100055128 - Polo; John M. ; et al.	2010-03-04
Eukaryotic layered vector initiation systems Grant 7,572,628 - Dubensky, Jr. , et al. August 11, 2	2009-08-11
Enhancement Of The Immune Response For Vaccine And Gene Therapy Applications App 20080292655 - Dubensky, JR.; Thomas W. ; et al.	2008-11-27
Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders Grant 7,034,010 - Davidson , et al. April 25, 2	2006-04-25
Method for the quantitation of alphavirus replicon particles Grant 6,767,699 - Polo , et al. July 27, 2	2004-07-27
Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders Grant 6,730,297 - Davidson , et al. May 4, 2	2004-05-04
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,465,634 - Dubensky, Jr. , et al. October 15, 2	2002-10-15
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,458,560 - Dubensky, Jr. , et al. October 1, 2	2002-10-01
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,451,592 - Dubensky, Jr. , et al. September 17, 2	2002-09-17
Alphavirus structural protein expression cassettes Grant 6,426,196 - Dubensky, Jr. , et al. July 30, 2	2002-07-30
Recombinant alphavirus particles Grant 6,376,236 - Dubensky, Jr. , et al. April 23, 2	2002-04-23
Eukaryotic layered vector initiation systems for production of recombinant proteins Grant 6,342,372 - Dubensky, Jr. , et al. January 29, 2	2002-01-29
Compositions and methods for packaging of alphavirus vectors Grant 6,329,201 - Polo , et al. December 11, 2	2001-12-11
Method for stimulating an immune response utilizing recombinant alphavirus particles Grant 6,015,694 - Dubensky, Jr. , et al. January 18, 2	2000-01-18
Eukaryotic layered vector initiation systems Grant 6,015,686 - Dubensky, Jr. , et al. January 18, 2	2000-01-18
Alphavirus vector constructs Grant 5,843,723 - Dubensky, Jr. , et al. December 1, 1	1998-12-01
Eukaryotic layered vector initiation systems Grant 5,814,482 - Dubensky, Jr. , et al. September 29, 1	1998-09-29
Alphavirus structural protein expression cassettes Grant 5,789,245 - Dubensky, Jr. , et al. August 4, 1	1998-08-04
Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells Grant 5,736,388 - Chada , et al. April 7, 1	1998-04-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.